Intraperitoneal mitoxantrone in the treatment of recurrent ascites from progressive epithelial ovarian cancer

被引：0
|
作者：
Marinaccio, M.
Mele, E.
De Marino, E.
Catacchio, R.
Pellegrino, C.
Sozzi, F.
Schonauer, S.
机构：
[1] Univ Med Sch, Dept Gynecol & Obstet, Bari, Italy
[2] Univ Bari, Bari, Italy
[3] S Andrea Hosp, Vercelli, Italy
[4] Univ Med Sch, Bari, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5051
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5051
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Weekly topotecan in the treatment of recurrent and persistent epithelial ovarian cancer
    Safra, Tamar
    Inbar, Moshe
    Menczer, Joseph
    Grisaro, Dan
    Glezerman, Marek
    Levy, Tally
    ANNALS OF ONCOLOGY, 2004, 15 : 136 - 136
  • [42] Current aspects of systemic treatment of recurrent epithelial ovarian cancer
    Claussen, Carlota
    Hanker, Lars
    GYNAKOLOGE, 2022, 55 (03): : 176 - 183
  • [43] Clinical significance of ascites in epithelial ovarian cancer
    Huang, H.
    Li, Y. J.
    Lan, C. Y.
    Huang, Q. D.
    Feng, Y. L.
    Huang, Y. W.
    Liu, J. H.
    NEOPLASMA, 2013, 60 (05) : 546 - 552
  • [44] TAMOXIFEN FOR RECURRENT AND PROGRESSIVE EPITHELIAL OVARIAN-TUMORS
    CAMPBELL, JJ
    ROME, RM
    QUINN, MA
    PEPPERELL, RJ
    MORGAN, WJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1985, 13 (03): : 150 - 151
  • [45] Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer
    Topuz, E
    Saip, P
    Aydiner, A
    Salihoglu, Y
    Berkman, S
    Bengisu, E
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (03) : 265 - 270
  • [46] Intraperitoneal bevacizumab for the palliation of malignant ascites in refractory ovarian cancer
    Hamilton, Chad A.
    Maxwell, G. Larry
    Chemofsky, Mildred R.
    Bernstein, Sarah A.
    Farley, John H.
    Rose, G. Scott
    GYNECOLOGIC ONCOLOGY, 2008, 111 (03) : 530 - 532
  • [47] Intraperitoneal chemotherapy as first-line treatment in the management of epithelial ovarian cancer
    Rekhraj, S.
    Kinross, J.
    Prabhudesai, S.
    Darzi, A.
    Ziprin, P.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (05) : 509 - 517
  • [48] Outcome following Hyperthermic Intraperitoneal Chemotherapy for Recurrent Epithelial Ovarian Cancer, the first Egyptian Experience
    Gareer, W. Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S540 - S540
  • [49] INTRAPERITONEAL MITOXANTRON APPLICATION IN PROGRESSIVE OVARIAN-CANCER
    SCHMID, H
    KAUFMANN, M
    GRISCHKE, EM
    KUBLI, F
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1987, 242 (1-4) : 391 - 391
  • [50] Effect of platinum sensitivity on the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent epithelial ovarian cancer
    Costales, Anthony B.
    Chambers, Laura
    Chichura, Anna
    Rose, Peter G.
    Mahdi, Haider
    Michener, Chad M.
    Yao, Meng
    Debernardo, Robert
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2021, 50 (05)
12345